Your browser doesn't support javascript.
loading
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine.
Tschismarov, Roland; Zellweger, Raphaël M; Koh, Min Jie; Leong, Yan Shan; Low, Jenny G; Ooi, Eng Eong; Mandl, Christian W; Ramsauer, Katrin; de Alwis, Ruklanthi.
Afiliación
  • Tschismarov R; Themis Bioscience GmbH, Vienna, Austria, a subsidiary of Merck & Co. Inc., Kenilworth, New Jersey, USA.
  • Zellweger RM; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Koh MJ; Viral Research and Experimental Medicine Centre, SingHealth-Duke NUS (ViREMiCS), Singapore.
  • Leong YS; Epidemiology, Public Health, & Impact, International Vaccine Institute, Seoul, Republic of Korea.
  • Low JG; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Ooi EE; Viral Research and Experimental Medicine Centre, SingHealth-Duke NUS (ViREMiCS), Singapore.
  • Mandl CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Ramsauer K; Viral Research and Experimental Medicine Centre, SingHealth-Duke NUS (ViREMiCS), Singapore.
  • de Alwis R; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
JCI Insight ; 6(21)2021 11 08.
Article en En | MEDLINE | ID: mdl-34582377
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Inmunización / Fiebre Chikungunya / Anticuerpos Antivirales Límite: Female / Humans / Male Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Inmunización / Fiebre Chikungunya / Anticuerpos Antivirales Límite: Female / Humans / Male Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos